Bonesupport
BONESUPPORT’s incoming CEO acquires shares
BONESUPPORT™, a leading company in orthobiologics for the treatment of bone disorders, today announces that incoming CEO Torbjörn Sköld has acquired 15,000 shares in BONESUPPORT at a price of 252,60 SEK per share. The total investment amounts to approximately 3,8 million SEK.
As previously communicated, Torbjörn Sköld will assume the role of CEO of BONESUPPORT on 1 September 2025.
Datum | 2025-06-05, kl 11:22 |
Källa | MFN |
